The Animal Genetics Market was valued at USD 5.91 Billion in 2023 and is projected to reach USD 9.72 Billion by 2031, growing at a CAGR of 6.4% during the forecast period. The animal genetics market Size is experiencing significant momentum driven by advancements in genetic technologies, increasing focus on sustainable animal farming, and a surge in demand for high-performance breeds across the globe.
The Genomic Services Market was valued at USD 25.56 billion in 2023 and is projected to reach USD 80.91 billion by 2031, growing at a compound annual growth rate (CAGR) of 15.5% from 2024 to 2031. The increasing integration of genomic technologies in drug discovery, diagnostics, and clinical research is a major driving force behind the expanding genomic services market size.
The Image-guided Biopsy Market size was valued at USD 1.79 billion in 2023 and is expected to reach USD 3.12 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.2% over the forecast period of 2024–2031. This growth is being driven by the increasing prevalence of cancer and other chronic diseases, as well as the rising demand for minimally invasive diagnostic procedures. The image-guided biopsy market size reflects the growing importance of precision and early diagnosis in modern healthcare systems.
The Biohacking Market Size was valued at USD 24.09 Billion in 2023 and is expected to reach USD 95.64 Billion by 2031, growing at a CAGR of 18.7% over the forecast period 2024-2031. The growing interest in self-optimization and personalized healthcare is accelerating the global biohacking market, particularly with increased consumer awareness and the adoption of smart wearable technology.
The Human Insulin Market size was valued at USD 19.58 Billion in 2023 and is projected to reach USD 30.44 Billion by 2031, growing at a CAGR of 5.7% over the forecast period. The rising global burden of diabetes, coupled with increasing awareness and access to treatment options, is driving demand for insulin products across developed and emerging economies. Human insulin market Size continue to reflect innovations in drug delivery systems and a shift towards biosimilar adoption, enhancing both affordability and accessibility.
According to a new research report, "Needle-Free Injector Market Size was valued at USD 142.32 million in 2023 and is expected to reach USD 393.04 million by 2031, growing at a CAGR of 13.6% over the forecast period 2024-2031." The market is witnessing rapid adoption due to rising concerns around needle-stick injuries and increased demand for painless drug delivery systems. Needle-Free Injector Market Size continues to attract interest from healthcare providers, pharmaceutical companies, and investors aiming to revolutionize patient experience and medication adherence.
According to a recent analysis, the global women's health therapeutics market was valued at USD 18.43 billion in 2023 and is expected to reach USD 28.31 billion by 2031. The women’s health therapeutics market Size is gaining significant traction due to increased awareness, expanding healthcare infrastructure, and the growing prevalence of chronic and reproductive health conditions specific to women.
According to a recent industry report, “The Mental Health Apps Market size was valued at USD 5.16 Billion in 2023 and is expected to reach USD 19.67 Billion by 2031, growing at a CAGR of 18.2% during the forecast period 2024-2031.” The mental health apps market size continues to gain attention globally as digital solutions take center stage in improving emotional wellness and therapy access.
As per the SNS Insider report, “The Medical Second Opinion Market size was valued at USD 4.17 billion in 2023 and is expected to reach USD 12.62 billion by 2031, growing at a CAGR of 14.8% over the forecast period 2024-2031.” This surge in market growth is largely driven by rising awareness among patients about the value of re-evaluating medical decisions to avoid misdiagnosis, unnecessary surgeries, and ineffective treatments. The Medical Second Opinion Market Size reflects the accelerating adoption of second opinion services, especially in critical conditions such as cancer, cardiac disorders, and neurological diseases.
The Molecular Diagnostics Market size was valued at USD 16.81 billion in 2023 and is expected to reach USD 37.70 billion by 2031, growing at a CAGR of 10.7% over the forecast period 2024–2031. This surge is driven by the growing need for faster, accurate, and cost-effective diagnostic techniques that are transforming the healthcare landscape globally.
The Veterinary Digital Pathology Market was valued at USD 78.20 million in 2023 and is projected to reach USD 166.02 million by 2031, growing at a compound annual growth rate (CAGR) of 9.8% during the forecast period of 2024–2031. Veterinary digital pathology Market Size is witnessing robust growth driven by the increasing prevalence of animal diseases, demand for faster and more accurate diagnostic tools, and the integration of artificial intelligence (AI) in veterinary healthcare.
The Peripheral Neuropathy Market Size was valued at USD 4.63 billion in 2023 and is expected to reach USD 8.42 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.7% over the forecast period of 2024-2031. Increasing awareness about nerve-related disorders and advancements in diagnostic technologies are driving growth in the Peripheral Neuropathy market. The rising prevalence of diabetes, cancer therapies, and other chronic ailments has led to an increase in peripheral nerve damage cases globally, creating a consistent demand for early diagnosis and effective treatment options.
The Multiple Sclerosis Market is projected to reach USD 41.99 billion by 2031, growing at a CAGR of 3.7% during the forecast period of 2024–2031. This notable growth is driven by the increasing prevalence of multiple sclerosis globally and the rising adoption of advanced therapeutic approaches aimed at improving patient outcomes.
The Hemophilia Market was valued at USD 12.68 billion in 2023 and is expected to reach USD 18.65 billion by 2031, growing at a CAGR of 4.9% during the forecast period 2024–2031. The global hemophilia market is witnessing robust growth driven by the increasing prevalence of bleeding disorders, growing patient awareness, and innovations in recombinant therapies. The rising demand for advanced treatment options and the adoption of prophylactic treatment methods have further bolstered the market outlook.
The global mental health market was valued at USD 410.7 billion in 2023 and is projected to reach USD 583.6 billion by 2031, growing at a CAGR of 4.47% over the forecast period. This growth is fueled by increasing awareness, reduced stigma, and the integration of mental health services into general healthcare systems, driving demand across demographics and geographies.
The FemTech Market was valued at USD 51.24 billion in 2023 and is projected to reach USD 144.08 billion by 2031, growing at a CAGR of 13.8% during the forecast period 2024-2031.FemTech market Size refers to a rapidly growing sector focused on leveraging technology to address women’s health issues, including fertility, pregnancy, menstrual health, menopause, and general wellness. This market is gaining traction due to rising awareness, increasing investment in female-centric healthcare, and the digitalization of medical services tailored for women.
The Digital Clinical Trials Market was valued at USD 8.76 billion in 2023 and is expected to reach USD 14.92 billion by 2031, growing at a CAGR of 6.9% over the forecast period 2024–2031.Digital clinical trials represent a transformative shift in the pharmaceutical and life sciences industries, integrating cutting-edge technologies such as artificial intelligence (AI), wearable devices, and remote monitoring to streamline clinical research and improve patient engagement.
The Digital Hearing Aids Market was estimated at USD 13.79 billion in 2023 and is projected to reach USD 21.32 billion by 2031, reflecting a steady compound annual growth rate (CAGR) of 6.4% during the forecast period. The digital hearing aids industry is experiencing significant growth due to advancements in audiology technology, increased awareness of hearing health, and the rising prevalence of hearing loss globally.
The Cognitive Behavioral Therapy (CBT) Market was valued at USD 5.02 billion in 2023 and is projected to reach USD 7.98 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% over the forecast period. This growth highlights the increasing global emphasis on mental health care and the rising demand for evidence-based therapeutic treatments such as cognitive behavioral therapy.
The Toxoid Vaccine Market size was valued at USD 7.3 Billion in 2023 and is projected to reach USD 13.67 Billion by 2031, growing at a CAGR of 8.2% over the forecast period 2024-2031. This growth is driven by increasing awareness of vaccine-preventable diseases and the expanding immunization programs globally, positioning the toxoid vaccine market as a vital segment in the biopharmaceutical industry.
